With ties to Stanford, Stealth Biosciences is organized around development of nanoscale devices able to measure and exert control over biological processes at the level of single cells. Stealth's devices represent a highly sensitive toolset for research, therapeutic, and diagnostic applications, including: high-throughput drug discovery, regenerative medicine, oncology, and neuroscience. The firm is building nano-engineered devices that integrate with biological cells to allow direct, non-destructive electrical and fluidic access. Stanford professors Nick Melosh and Craig Garner had developed two nanomaterial technologies 'Nanostraws and Stealth Probes' that provide direct, non-destructive electrical and fluidic access to cells. Stealth offers Nanostraws that allow two-way access to individual cells; and Stealth Electrodes to automate long-term intracellular electrical recordings of neurons and heart cells. The firm's product applications include personalized medicine, stem cells, drug discovery, oncology, and neuroscience.
